Join Us in Celebrating Southeastern Massachusetts’ Life Science Campus for Innovation and Innovators.

Mansfield Bio-Incubator, Bioinc, held Grand Opening of the Phase II expansion and Open House Networking Event

Wednesday, October 19, 2022

10:30 am to 2:30 pm

at Mansfield Bio-Incubator 241 Francis Avenue Mansfield, MA 02048

With over twenty (20) life science companies in place, we have room for a few more. Several of our member companies highlighted the benefits of being part of the growing South of Boston innovation ecosystem.

We invite you to view our portfolio companies at: https://www.bioinc.org/portfolio/

Come see for yourself how the Boston/Cambridge biotechnology supercluster now extends south of the city to form a Boston-Providence innovation corridor. The groundbreaking R&D activities going on within our laboratories are making a lasting contribution to the growth of the life science ecosystem in Southern New England. We are deepening the partnership with Wheaton College’s Diana Davis Spencer Entrepreneurship Center and other universities in the region. Our goal of creating a large campus consisting of R&D and manufacturing facilities is well underway.

Our Phase II expansion was made possible through Massachusetts Life Science Center’s Capital Program Grant and the matching contribution from a private foundation. Bioinc is celebrating the MLSC commitment to developing the life sciences across the Commonwealth, which includes the growing Southeastern Massachusetts life science cluster.

The new Phase II buildout’s key feature is a state-of-the-art BSL-2 laboratory space. The laboratory project is a renovation of an old glass factory and was built based on the modern concept of the lab design. Mansfield Bio-Incubator is a combination of open and private laboratory spaces seamlessly intertwined with meeting space to stimulate collaboration and creativity. We serve a variety of companies from a single founder start-up to a medium-size company ready to start product manufacturing.

In addition to the ribbon-cutting, the keynote program featured local, state, and federal elected officials, trade organizations, and local institutions of higher education. Several of Mansfield Bio-Incubator’s member companies presented their work.

Come see our world-class lab and hear how the Bio-incubator’s innovative startup companies are transforming the world with game-changing inventions in life science!

The grand opening coincided with the opening of a 700 square feet laboratory suite by Phenomenex, part of Danaher Corporation. The laboratory will have cutting-edge analytical instruments such as mass spectrometers, UHPLC, and sample preparation tools and technologies. The high-end equipment will be available to the member companies. Coupled with the decades of scientific expertise, this lab will serve as an indispensable asset to our current and future startups to turbocharge their projects in a synergistic fashion.

Agenda:

10:30 am: Registration, Networking and Refreshments

11:00 am: Keynote Program

11:45 am: Ribbon Cutting

12:00 noon: Lunch

12:45 pm: Company Presentations

1:45 pm-2:30 pm: Product Demonstrations, Continued Networking, and Facility Tours

Keynote Speakers:

Russ Yukhananov, PhD, President, and Alexander Margulis, PhD, COO, Mansfield Bio-Incubator

Jake Auchincloss, Massachusetts Representative

Margaret LaForest, Boston Regional Director at MA Office of Business Development at Commonwealth of Massachusetts

Paul Feeney, Massachusetts State Senator

Ben Bradford, Vice President of Economic Development and Workforce, Massachusetts Biotechnology Council

Kenn Turner, President and CEO, Massachusetts Life Sciences Center

Kevin Dumas, Town Manager, Town of Mansfield, MA

Imran Chowdhury, PhD , Diana Davis Spencer Chair of Social Entrepreneurship, Wheaton College

Presenting Companies:

Entrinsic Bioscience leverages proprietary biomapping and electrophysiology platform to identify, target, and validate combinations of amino acids as functional ingredients and APIs that deliver highly specific, efficient, and life -enhancing health benefits.

Emitech is developing a wearable bracelet for real-time and reliable narcotic detection that offers wireless communication with a user interface (smartphone, computer), with multiple sensors in the array to test for many narcotics (mostly synthetic).

Phenomenex is a global technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers in industrial, clinical research, governmental and academic laboratories.

Hilltop Bio is a veterinary biotech company developing innovative regenerative therapies focused on helping our four-legged friends reduce inflammation from injuries or disease. The company’s strategy is to identify key inflammatory diseases in companion animals and work to provide targeted regenerative therapies to help reduce inflammation and normalize damaged tissue function. Hilltop Bio has developed a strong pipeline of innovative therapies across many therapeutic classes, alongside cGMP, cGTP manufacturing capabilities, and a developing intellectual property portfolio.

3Daughters is a Woman’s Healthcare Company developing a new evolutionary intrauterine device (IUD) for contraception, based on physics, that conforms to a woman’s body. This revolutionary magnetic frameless IUD addresses the problems with the outdated T-shape design of current IUDs. These include significant insertion pain, expulsion, and uterine perforation along with the nuisance factor of the attached strings for IUD retrieval.

Beyond Biotech provides rAAV-related services to biological and medical researchers in universities, institutes, hospitals and biopharmaceutical companies. Our services include rAAV vector construction, rAAV-based shRNA and artificial miRNA design/construction/assay, rAAV packaging, and cell-based assay for gene therapy researchers.

Oncovolution is developing a new generation of platinum-based chemotherapies designed to increase tolerable dosages for patients.

Therabene is developing highly targeted PROTAC molecules to attack cancers, as well as viral and autoimmune diseases.

Neuronity is a biotech startup company developing First-in-Class immune therapy for age-related neurodegenerative diseases.

UpLevel Foods produce condiments that contain the most optimal nutrient density, and that’s important for the health and vitality of you and your family.

Turtle Health is bringing fertility care to your doorstep. They are developing the most accurate at-home fertility testing options to provide you with personalized, medically meaningful information to help you plan and manage your fertility journey, early and affordably.

Eighty Eight Pharma is developing two products, the Oppotoxy™ Bottle, and the CAREapace Container.